ZIVO Bioscience, Inc. ZIVO
Nov 5, 2026, 11:38 AM EST
- YTD
- -16.67%
- 1 year
- -44.53%
- Market cap
- 30.56M
- Revenue (ttm)
- 15.85K
- EPS (ttm)
- -2.18
- Shares out
- 1.82M
- Forward P/E
- -1.64
- YTD return
- -16.67%
- 1-year return
- -44.53%
- Volume
- 35
- Avg volume
- 525
- Open
- 8.12
- Previous close
- 8.00
- Day's range
- 7.25 – 8.12
- 52-week range
- 1.11 – 13.29
- Beta
- -0.07
- Analysts
- Buy
- Price target
- 36.00 (+396.6%)
- Earnings date
- Aug 14, 2023
5D -3.24 (-30.89%)
Key statistics
- Enterprise value
- 2.42M
- PEG ratio
- 0.00
- Price / sales
- 150.96
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -3.34M
- Total cash
- 1.48M
- Total debt
- 1.50M
- Return on equity
- -3956.02%
- Short % of float
- 2.61%
- 50-day average
- 1.98
- 200-day average
- 11.10
Analyst view
Consensus: buy
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 14, 2023
Expected Aug 14, 2023. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.67 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -2.78 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -0.47 | — | — |
| Mar 15, 2024 | Dec 1, 2023 | 0.00 | -0.96 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 10, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 14, 2021 | Maxim Group | init | — | Buy |
About ZIVO Bioscience, Inc.
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- zivobioscience.com
News
$2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying 
11 Consumer Staples Stocks Moving In Thursday's Intraday Session - Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Stocks That Hit 52-Week Lows On Thursday - Stocks That Hit 52-Week Lows On Monday
- Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday 
50 Biggest Movers From Yesterday 
39 Stocks Moving In Wednesday's Mid-Day Session 
20 Stocks Moving in Wednesday's Pre-Market Session
Your note
Sign in to keep a note on ZIVO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CORNELL ALISON A | Director | Purchase | Dec 12, 2022 | 27,000 |
| MAGGIORE CHRISTOPHER D | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 12, 2023 | 179,124 |
| MASTERSON NOLA E | Director | Purchase | Dec 18, 2022 | 5,198 |
| PAYNE JOHN BERNARD | Chief Executive Officer | Purchase | Dec 18, 2022 | 9,401 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.80% | 1,023,870 | 2.48M | Jun 29, 2023 |
| Geode Capital Management, LLC | 2.61% | 272,788 | 660.15K | Jun 29, 2023 |
| Vanguard Group Inc | 1.11% | 116,330 | 281.52K | Jun 29, 2023 |
| Corecap Advisors, LLC | 0.25% | 26,166 | 65.42K | Dec 30, 2022 |
| Schechter Investment Advisors, LLC | 0.21% | 22,250 | 53.84K | Jun 29, 2023 |
| Column Capital Advisors, LLC | 0.11% | 12,000 | 29.04K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 2.55% | 266,026 | 731.57K | May 30, 2023 |
| Vanguard Total Stock Market Index Fund | 0.78% | 81,788 | 197.93K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.29% | 29,851 | 72.24K | Jun 29, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 3,401 | 9.35K | May 30, 2023 |